Join us as we celebrate 20 years advancing science and speeding treatments to patients

Since 1996, Friends has pioneered innovative partnerships and policy initiatives to advance cancer treatment and research.

We hope you will join us for this year-long celebration of Friends’  20th Anniversary as we look to the future of cancer research.

Read More

Regulatory Decision-Making Meets the Real World

Friends publishes commentary in Science Translational Medicine and Whitepaper Report on patient-centered drug development. Links below:

AAAS' Science Translational Medicine

Friends Whitepaper - Enhancing Use of Patient-Centered Data in Regulatory Decision Making


19th Annual Cancer Leadership Awards Reception

Friends Honors Rep. Fred Upton, Rep. Diana DeGette, and President Marlene Malek as Dr. Francis Collins sings, "If Not Now, Tell Me When"

Read More

Ellen Sigal Op-Ed in The Hill on Updating FDA Structure

Ellen Sigal Calls for updated FDA structure for 21st Century science and patient needs

Read More

Accelerating Science and Technology

Friends of Cancer Research is our country's leading voice in advocating for policies and solutions that will get treatments to patients in the safest and quickest way possible.

Read More

New collaborative clinical trial launches

Researchers, drug developers, and patient advocates share their thoughts about Lung-MAP

Read More

Breakthrough Therapies In Action

The FDA's Breakthrough Therapy program continues to accelerate the development and approval of groundbreaking new therapies.

Read More

Breakthrough Designations

View More

Affinity enhanced T-cell therapy - (Adaptimmune)

targeting NY-ESO in synovial sarcoma for HLA-A*201, HLA-A*205 or HLA-A*206 allele-positive patients with inoperable or metastatic synovial sarcoma who have received prior chemotherapy and whose tumor expresses the NY-ESO-1 tumor antigen


Sacituzumab govitecan (IMMU-132) - (Immunomedics)

for the treatment of patients with triple-negative breast cancer (TNBC) following at least 2 treatments for metastatic disease